FDA 510(k) Clearance CT-based BMD Technology

Summary by 6ix AI

This clearance allows for the integration of quantitative bone health assessment into existing CT imaging workflows, potentially streamlining orthopaedic imaging and surgical planning. The company plans to pursue further FDA clearance to extend this technology to its HiRise platform, which focuses on weight-bearing CT imaging.

Written by 6ix AI from the company’s filing. How 6ix writes summaries